Pages that link to "Q38076265"
Jump to navigation
Jump to search
The following pages link to Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis (Q38076265):
Displaying 50 items.
- Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis (Q27021762) (← links)
- Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Q28081266) (← links)
- Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database (Q28542731) (← links)
- HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes (Q28551618) (← links)
- Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy (Q28553516) (← links)
- Modeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort Study (Q28555157) (← links)
- Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals (Q30240127) (← links)
- The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis (Q30245495) (← links)
- Developments in HIV-1 immunotherapy and therapeutic vaccination. (Q30364312) (← links)
- Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria (Q32112299) (← links)
- Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children (Q34137766) (← links)
- Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects (Q34306474) (← links)
- Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study (Q34445856) (← links)
- Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection (Q34976284) (← links)
- Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial) (Q35114865) (← links)
- An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa (Q35147717) (← links)
- Inhibition of major drug metabolizing CYPs by common herbal medicines used by HIV/AIDS patients in Africa-- implications for herb-drug interactions (Q35162440) (← links)
- Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy (Q35205900) (← links)
- Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz (Q35547048) (← links)
- Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study (Q35717749) (← links)
- The Influence of Medication Attitudes on Utilization of Antiretroviral Therapy (ART) in Indonesian Prisons (Q35785892) (← links)
- Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation (Q35910664) (← links)
- Improved survival in HIV treatment programmes in Asia (Q35951760) (← links)
- Clinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in Kenya (Q36092410) (← links)
- Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review (Q36162401) (← links)
- Self-Reported Side Effects and Adherence to Antiretroviral Therapy in HIV-Infected Pregnant Women under Option B+: A Prospective Study (Q36167659) (← links)
- Risk factors associated with sexually transmitted infections among HIV infected men who have sex with men. (Q36270155) (← links)
- An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China (Q36277181) (← links)
- Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan (Q36286145) (← links)
- Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients (Q36426953) (← links)
- Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial (Q36501872) (← links)
- Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention (Q37071435) (← links)
- EFV/FTC/TDF-associated hepatotoxicity: a case report and review (Q37139458) (← links)
- Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa (Q37330398) (← links)
- Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China (Q37379483) (← links)
- Management of BU-HIV co-infection (Q38221645) (← links)
- The future role of CD4 cell count for monitoring antiretroviral therapy (Q38281773) (← links)
- Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing? (Q38630880) (← links)
- Developments in early diagnosis and therapy of HIV infection in newborns. (Q38648601) (← links)
- Advances in the Pharmacogenomics of Adverse Drug Reactions. (Q38663764) (← links)
- Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children (Q38850249) (← links)
- Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis (Q39553824) (← links)
- Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia (Q39805283) (← links)
- Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin (Q40050910) (← links)
- Moving forward with treatment options for HIV-infected children. (Q40063042) (← links)
- Choice of initial antiretroviral drugs and treatment outcomes among HIV-infected patients in sub-Saharan Africa: systematic review and meta-analysis of observational studies (Q40070125) (← links)
- Nevirapine induced mitochondrial dysfunction in HepG2 cells. (Q40072847) (← links)
- Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility (Q40130609) (← links)
- A cross-sectional study of liver function tests in HIV-infected persons in Western India (Q40357994) (← links)
- Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz? (Q40825222) (← links)